FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146378328> ?p ?o ?g. }

• W2146378328 endingPage "1065" @default.
• W2146378328 startingPage "1059" @default.
• W2146378328 abstract "Purpose To determine the relationship between quantitative estrogen-receptor (ER) and progesterone-receptor (PgR) expression and human epidermal growth factor 2 (HER-2) status with time to recurrence (TTR) in postmenopausal women with hormone receptor–positive primary breast cancer treated with anastrozole or tamoxifen as adjuvant therapy. Patients and Methods Formalin-fixed, paraffin-embedded tumor blocks were retrospectively collected from patients in the monotherapy arms of the Arimidex, Tamoxifen Alone or in Combination (ATAC) trial and centrally tested for ER, PgR and HER-2. ER and PgR were scored using continuous scales and HER-2 was scored as 0 to 3+ with 2+ cases being analyzed by fluorescence in situ hybridization. Results Blocks were collected from 2,006 of 5,880 eligible patients. Tissue was assessable and ER and/or PgR positivity confirmed centrally in 1,782 cases. In these, TTR was longer for anastrozole than for tamoxifen by a similar extent to that in the overall trial. None of the three biomarkers identified a set of patients with differential benefit from anastrozole over tamoxifen. Patients with low ER, low PgR, and high HER-2 expression had a poorer prognosis with either drug. Only 2.6% of patients in the highest quartile of PgR experienced recurrence after 5 years, compared with 13.2% in the lowest quartile. Conclusion Quantitative expression of ER and PgR and HER-2 status did not identify patients with differential relative benefit from anastrozole over tamoxifen: TTR was longer for anastrozole than for tamoxifen in all molecular subgroups. Low ER or PgR or high HER-2 expression are associated with a high risk of recurrence with either anastrozole or tamoxifen." @default.
• W2146378328 created "2016-06-24" @default.
• W2146378328 creator A5001413138 @default.
• W2146378328 creator A5015575554 @default.
• W2146378328 creator A5018809857 @default.
• W2146378328 creator A5022237789 @default.
• W2146378328 creator A5023115832 @default.
• W2146378328 creator A5025224681 @default.
• W2146378328 creator A5030451537 @default.
• W2146378328 creator A5057689412 @default.
• W2146378328 creator A5059918400 @default.
• W2146378328 creator A5061618799 @default.
• W2146378328 creator A5066328703 @default.
• W2146378328 creator A5070904518 @default.
• W2146378328 creator A5071158497 @default.
• W2146378328 creator A5074887483 @default.
• W2146378328 creator A5075105813 @default.
• W2146378328 creator A5076841165 @default.
• W2146378328 creator A5079420496 @default.
• W2146378328 creator A5080602223 @default.
• W2146378328 creator A5081413747 @default.
• W2146378328 creator A5085122679 @default.
• W2146378328 date "2008-03-01" @default.
• W2146378328 modified "2023-10-03" @default.
• W2146378328 title "Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial" @default.
• W2146378328 cites W1453600927 @default.
• W2146378328 cites W1892496998 @default.
• W2146378328 cites W1961026612 @default.
• W2146378328 cites W1988561376 @default.
• W2146378328 cites W2035810660 @default.
• W2146378328 cites W2038180706 @default.
• W2146378328 cites W2041155982 @default.
• W2146378328 cites W2097908725 @default.
• W2146378328 cites W2114167623 @default.
• W2146378328 cites W2116937653 @default.
• W2146378328 cites W2121656289 @default.
• W2146378328 cites W2125737092 @default.
• W2146378328 cites W2138317169 @default.
• W2146378328 cites W2141232624 @default.
• W2146378328 cites W2161550802 @default.
• W2146378328 cites W2165037690 @default.
• W2146378328 cites W2165432902 @default.
• W2146378328 doi "https://doi.org/10.1200/jco.2007.12.9437" @default.
• W2146378328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18227529" @default.
• W2146378328 hasPublicationYear "2008" @default.
• W2146378328 type Work @default.
• W2146378328 sameAs 2146378328 @default.
• W2146378328 citedByCount "403" @default.
• W2146378328 countsByYear W21463783282012 @default.
• W2146378328 countsByYear W21463783282013 @default.
• W2146378328 countsByYear W21463783282014 @default.
• W2146378328 countsByYear W21463783282015 @default.
• W2146378328 countsByYear W21463783282016 @default.
• W2146378328 countsByYear W21463783282017 @default.
• W2146378328 countsByYear W21463783282018 @default.
• W2146378328 countsByYear W21463783282019 @default.
• W2146378328 countsByYear W21463783282020 @default.
• W2146378328 countsByYear W21463783282021 @default.
• W2146378328 countsByYear W21463783282022 @default.
• W2146378328 countsByYear W21463783282023 @default.
• W2146378328 crossrefType "journal-article" @default.
• W2146378328 hasAuthorship W2146378328A5001413138 @default.
• W2146378328 hasAuthorship W2146378328A5015575554 @default.
• W2146378328 hasAuthorship W2146378328A5018809857 @default.
• W2146378328 hasAuthorship W2146378328A5022237789 @default.
• W2146378328 hasAuthorship W2146378328A5023115832 @default.
• W2146378328 hasAuthorship W2146378328A5025224681 @default.
• W2146378328 hasAuthorship W2146378328A5030451537 @default.
• W2146378328 hasAuthorship W2146378328A5057689412 @default.
• W2146378328 hasAuthorship W2146378328A5059918400 @default.
• W2146378328 hasAuthorship W2146378328A5061618799 @default.
• W2146378328 hasAuthorship W2146378328A5066328703 @default.
• W2146378328 hasAuthorship W2146378328A5070904518 @default.
• W2146378328 hasAuthorship W2146378328A5071158497 @default.
• W2146378328 hasAuthorship W2146378328A5074887483 @default.
• W2146378328 hasAuthorship W2146378328A5075105813 @default.
• W2146378328 hasAuthorship W2146378328A5076841165 @default.
• W2146378328 hasAuthorship W2146378328A5079420496 @default.
• W2146378328 hasAuthorship W2146378328A5080602223 @default.
• W2146378328 hasAuthorship W2146378328A5081413747 @default.
• W2146378328 hasAuthorship W2146378328A5085122679 @default.
• W2146378328 hasConcept C121608353 @default.
• W2146378328 hasConcept C126322002 @default.
• W2146378328 hasConcept C143998085 @default.
• W2146378328 hasConcept C2776215463 @default.
• W2146378328 hasConcept C2777176818 @default.
• W2146378328 hasConcept C2777982462 @default.
• W2146378328 hasConcept C44249647 @default.
• W2146378328 hasConcept C530470458 @default.
• W2146378328 hasConcept C68443243 @default.
• W2146378328 hasConcept C71924100 @default.
• W2146378328 hasConcept C84606932 @default.
• W2146378328 hasConcept C98717036 @default.
• W2146378328 hasConceptScore W2146378328C121608353 @default.
• W2146378328 hasConceptScore W2146378328C126322002 @default.
• W2146378328 hasConceptScore W2146378328C143998085 @default.
• W2146378328 hasConceptScore W2146378328C2776215463 @default.
• W2146378328 hasConceptScore W2146378328C2777176818 @default.

• next